コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 izational level (i.e., global, national, and corporate).
5 siness supplier, suggesting that large-scale corporate agreements are necessary to make corn oil fryi
6 database contains ring structures from both corporate and commercial databases, along with character
9 icantly on the stage of development (in both corporate and technology) of the physician entrepreneur'
10 ians; leaders in the life insurance, private corporate, and prepaid health care industries; and medic
11 by a widespread skepticism of governmental, corporate, and professional dominance; unprecedented eco
12 f various individuals as well as government, corporate, and university sponsors of scientific work.
16 ng answers to infrequent research questions, corporate bioinformatics is breaking down under the floo
17 -control policy instruments have, along with corporate citizenship, been the predominant means for br
21 d small-to-medium private practices; and the corporate commercial hospital sector, which is growing r
22 ine socioeconomic impact trends arising from corporate, community and diversified funding structures.
23 scribes the different and common features of corporate compared to academic environments, and highlig
25 ock solutions of compounds registered in the corporate compound collection as synthetic reactants.
26 H4 receptor, a high throughput screen of our corporate compound collection identified compound 6 as a
27 the phenotypic screening of the AstraZeneca corporate compound collection, N-aryl-2-aminobenzimidazo
28 by in silico similarity searches within the corporate compound deck based on rh-renin active site do
29 ees (39%), corporate grant recipients (34%), corporate consultants (23%), or shareholders (18%) of th
31 udy using the Veterans Health Administration Corporate Data Warehouse from 1999 to 2013 to evaluate (
33 sults from model selected molecules from the corporate database and seven computationally derived sma
37 onals with a strengthened basis to influence corporate decision making, particularly when linked to c
38 ion of environmental costs and benefits into corporate decision-making has enormous, but as yet unful
44 realizing a major breakthrough in reporting corporate environmental impacts and dependencies has nev
45 at retirement, especially if the returns on corporate equities are comparable with historical return
46 RSNA abstracts in which authors disclosed corporate financial relationships were twice as likely a
47 ciated incentives, profits, and advertising; corporate food vending and associated incentives and pro
50 mal, involving universities, start-up firms, corporate giants, and venture capitalists play a major r
52 s were for authors who were employees (39%), corporate grant recipients (34%), corporate consultants
53 ractitioners-both unlicensed and licensed-to corporate hospital chains and large private insurers.
56 ic partnerships extend beyond a university's corporate interests to involve institutional decision ma
60 erability to supply restriction (VSR) at the corporate level for an invented solar cell manufacturing
63 ) studies of initial screening hits from our corporate library of compounds and a structurally relate
65 n of paintings placed next to the sponsoring corporate logo, an effect that correlates with modulatio
68 iled, and little evidence was found in TTCs' corporate materials that snus is central to their busine
71 search Council template, is designed to help corporate, national, and global stakeholders conduct ris
81 of 87 (32%) of 271 abstracts with disclosed corporate relationships discussed non-FDA-approved use o
83 isions toward better environmental outcomes, corporate reporting frameworks need to develop scientifi
84 ed promising points of intervention, whereas corporate researchers have performed the downstream, app
85 s deceleration are precariously dependent on corporate risk management, and public policies have reli
86 cation of novel antibacterial compounds from corporate screening collections, physical properties of
88 lators, an observation that has parallels in corporate settings where middle managers must interact m
89 nt for issues beyond tobacco; and presenting corporate social responsibility (CSR) as an alternative.
91 c arguments, rebrand political activities as corporate social responsibility, and establish and use t
93 omatoes: insights can be used to help inform corporate sourcing strategies and certification schemes.
94 ied limits on faculty financial interests in corporate sponsors of research, 12% (n = 11) specified l
96 shallow pretreatment recession (< 4 mm), and corporate sponsorship all resulted in significantly (P <
97 n four times as much funding through greater corporate sponsorship and use of a wider variety of fina
98 rtners or competition among universities for corporate sponsorship that could erode academic standard
100 mmunity funding structures are preferable to corporate structures, yet lack supporting quantitative d
102 influences other than economics, the path to corporate success is unlikely to be a compassionate one.
104 such as national income and wealth accounts, corporate sustainability reporting, land-use planning, a
108 from the Department of Veterans Affairs (VA) Corporate Warehouse Data from 2015, we evaluated HIV, HC
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。